Literature DB >> 6423793

Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites.

H Nau, H Helge, W Luck.   

Abstract

The total concentrations of valproic acid were higher in cord serum than in the serum of epileptic mothers given this drug (fetal/maternal total concentration ratios 1.7 +/- 0.5). The maternal free fractions of VPA correlated with the fetal accumulation of the drug. The fetal/maternal free fraction ratios (0.47 +/- 0.24) correlated inversely with the fetal/maternal total concentration ratios. The free concentrations of VPA in fetal blood were similar to those in maternal blood. These results obtained in vivo were confirmed by an in vitro study in which the drug had been added to drug-free serum samples. The free fractions (x100) of VPA in the maternal serum at birth (27.3 +/- 6.3) were significantly higher than in the serum of adult controls (8.0 +/- 2.4) and in cord serum (11.8 +/- 1.3). The pattern of VPA metabolite binding in the three groups was similar to that of VPA, although an unsaturated metabolite (2-en) was bound to a much higher degree than VPA (greater than 98%). The high total drug load in the fetus was partially displaced from binding sites during the first few postnatal days. The free fractions of the drug and metabolites in the neonates were almost twice as high as those in the fetus at birth. The decreased protein binding of VPA in the mothers at birth and in the neonates during the first postnatal week was related to increased free fatty acid levels. VPA concentrations in mother's milk were much lower than the free concentrations in plasma milk/plasma ratios 0.025 +/- 0.01). In neonates, half-lives for VPA were prolonged (43 +/- 14 hours). Our results indicate that increased free fatty acid concentrations in the maternal blood at the time of birth result in partial displacement of VPA from maternal binding sites, additional placental transfer, and thus fetal accumulation of the drug. The high drug load in the fetus is subsequently partially displaced after birth, resulting in increased free fractions and free concentrations of VPA in the neonate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423793     DOI: 10.1016/s0022-3476(84)80567-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co-medication, and the presence of spina bifida.

Authors:  J G Omtzigt; H Nau; F J Los; L Pijpers; D Lindhout
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Anticonvulsants in pregnancy.

Authors:  R Meadow
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

3.  Prescribing in pregnancy. Epilepsy and anticonvulsant drugs.

Authors:  A Hopkins
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

Review 4.  Anticonvulsant use during lactation.

Authors:  S Hägg; O Spigset
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

5.  Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.

Authors:  R L Semmes; D D Shen
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  Placental transfer and neonatal elimination of mono-unsaturated metabolites of valproic acid.

Authors:  T Kondo; K Otani; T Hirano; S Kaneko
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

7.  Anticonvulsants in the newborn period.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

Review 8.  Lactation studies of anticonvulsants: a quality review.

Authors:  Douwe H van der Meer; Andre Wieringa; Ilse Wegner; Bob Wilffert; Peter G J Ter Horst
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

Review 9.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 10.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.